DCE-MRI for Early Prediction of Response in Hepatocellular Carcinoma after TACE and Sorafenib Therapy: A Pilot Study (2018)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.5334/jbsr.1278

PubMed Identifier: 30039052

Publication URI: http://europepmc.org/abstract/MED/30039052

Type: Journal Article/Review

Parent Publication: Journal of the Belgian Society of Radiology

Issue: 1

ISSN: 2514-8281